Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_assertion wasGeneratedBy ECO_0000203 NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_assertion wasDerivedFrom befree-20140225 NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_assertion SIO_000772 19050699 NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_assertion evidence source_evidence_literature NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_assertion description "[Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP586746.RAA8dJ0BxZ-KnHpPjWfpU9Iv0R9eX7XFXapNxok_d1RsY130_provenance.